|
|
40
|
|
|
41817
|
|
|
REMICADE 100MG INJ (JAC/STO) INFLIXIMAB
|
|
|
INFLIXIMAB
|
|
|
REMICADE
|
|
|
20ML VIAL
|
|
|
C
|
|
|
1,460.17
|
|
|
1,460.17
|
|
|
100MG
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
JAC
|
|
|
JANSSEN-CILAG
|
|
|
STO
|
|
|
BRYDEN STOKES LTD
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|